We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

LEO Pharma To Purchase Peplin For $287.5M

Law360 (September 3, 2009, 12:26 PM EDT) -- Danish pharmaceutical company LEO Pharma A/S has announced plans to acquire Peplin Inc. for $287.5 million, a move intended to bolster LEO's line of dermatology products.

The companies announced the acquisition...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.